Venn Life Sciences Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
170
- Latest Deal Type
-
M&A
- Financing Rounds
-
7
- Investments
-
10
Venn Life Sciences General Information
Description
Provider of consulting and clinical trial services intended to serve the healthcare sector. The company offer servies such as drug development consultancy, clinical pharmacology, PK/PD and translational modelling and simulation, non-clinical development, medical writing services, regulatory affairs consultancy, data management, statistics, study design & methodology, project management and clinical trials legal service.
Contact Information
Website
www.vennlifesciences.com(Operating Subsidiary)
Corporate Office
- Lage Mosten 29
- 4822 NK Breda
- Netherlands
Corporate Office
- Lage Mosten 29
- 4822 NK Breda
- Netherlands
Venn Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Venn Life Sciences Patents
Venn Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2496215-A2 | Antimicrobial and anti-acne formulations | Active | 03-Nov-2009 | ||
| EP-2496215-B1 | Antimicrobial and anti-acne formulations | Inactive | 03-Nov-2009 | ||
| ES-2534843-T3 | Antimicrobial and anti-acne formulations | Active | 03-Nov-2009 | A61K9/0014 |
Venn Life Sciences Signals
Venn Life Sciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Venn Life Sciences Investments & Acquisitions (10)
Venn Life Sciences’s most recent deal was a Merger/Acquisition with hVIVO for . The deal was made on 09-Dec-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| hVIVO | 09-Dec-2019 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Deepverge | 05-Apr-2017 | IPO | Personal Products | ||
| Kinesis Pharma | 16-Oct-2015 | Merger/Acquisition | Consulting Services (B2B) | ||
| Cardinal Systems Paris | 05-Aug-2014 | Merger/Acquisition | Consulting Services (B2B) | ||
| Evocutis (trading assets) | 28-Feb-2014 | Corporate Asset Purchase | Buildings and Property |
Venn Life Sciences Exits (1)
Venn Life Sciences’s most recent exit was on 05-Apr-2017 from Deepverge. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Deepverge | 05-Apr-2017 | Completed |
|
Venn Life Sciences FAQs
-
When was Venn Life Sciences founded?
Venn Life Sciences was founded in 2007.
-
Where is Venn Life Sciences headquartered?
Venn Life Sciences is headquartered in Breda, Netherlands.
-
What is the size of Venn Life Sciences?
Venn Life Sciences has 170 total employees.
-
What industry is Venn Life Sciences in?
Venn Life Sciences’s primary industry is Other Healthcare Services.
-
Is Venn Life Sciences a private or public company?
Venn Life Sciences is a Private company.
-
What is Venn Life Sciences’s current revenue?
The current revenue for Venn Life Sciences is .
-
How much funding has Venn Life Sciences raised over time?
Venn Life Sciences has raised $10.7M.
-
Who are Venn Life Sciences’s investors?
Armscote Investment Company, Calculus Capital, and Seneca Partners (Haydock) have invested in Venn Life Sciences.
-
When was Venn Life Sciences acquired?
Venn Life Sciences was acquired on 28-Jun-2019.
-
Who acquired Venn Life Sciences?
Venn Life Sciences was acquired by hVIVO.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process